MS patients may soon swap IV drips for a simple shot

NCT ID NCT07211633

Recruiting now Disease control Sponsor: TG Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 22 times

Summary

This study tests if a shot (subcutaneous) of the drug ublituximab works as well as the standard IV version for people with relapsing multiple sclerosis. About 360 adults with MS will receive either the shot or the IV, and researchers will measure drug levels in the blood and monitor safety. The goal is to offer a more convenient treatment option without losing effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

TG Therapeutics Investigational Trial Site
RECRUITING

Banja Luka, 78000, Bosnia and Herzegovina
TG Therapeutics Investigational Trial Site
RECRUITING

Bihać, 77000, Bosnia and Herzegovina
TG Therapeutics Investigational Trial Site
RECRUITING

Mostar, 71000, Bosnia and Herzegovina
TG Therapeutics Investigational Trial Site
RECRUITING

Saravejo, 71000, Bosnia and Herzegovina
TG Therapeutics Investigational Trial Site
RECRUITING

Pleven, 5800, Bulgaria
TG Therapeutics Investigational Trial Site
RECRUITING

Plovdiv, 4000, Bulgaria
TG Therapeutics Investigational Trial Site
RECRUITING

Sofia, 1000, Bulgaria
TG Therapeutics Investigational Trial Site
RECRUITING

Veliko Tarnovo, 5000, Bulgaria
TG Therapeutics Investigational Trial Site
RECRUITING

Varaždin, 42000, Croatia
TG Therapeutics Investigational Trial Site
RECRUITING

Zagreb, 10000, Croatia
TG Therapeutics Investigational Trial Site
RECRUITING

Brno, 65691, Czechia
TG Therapeutics Investigational Trial Site
RECRUITING

Hradec Králové, 50005, Czechia
TG Therapeutics Investigational Trial Site
RECRUITING

Jihlava, 58601, Czechia
TG Therapeutics Investigational Trial Site
RECRUITING

Ostrava, 70300, Czechia
TG Therapeutics Investigational Trial Site
RECRUITING

Pardubice, 53002, Czechia
TG Therapeutics Investigational Trial Site
RECRUITING

Zlín, 76275, Czechia
TG Therapeutics Investigational Trial Site
RECRUITING

Tbilisi, 0112, Georgia
TG Therapeutics Investigational Trial Site
RECRUITING

Tbilisi, 0114, Georgia
TG Therapeutics Investigational Trial Site
RECRUITING

Tbilisi, 0159, Georgia
TG Therapeutics Investigational Trial Site
RECRUITING

Tbilisi, 0172, Georgia
TG Therapeutics Investigational Trial Site
RECRUITING

Tbilisi, 0178, Georgia
TG Therapeutics Investigational Trial Site
RECRUITING

Tbilisi, 0179, Georgia
TG Therapeutics Investigational Trial Site
RECRUITING

Tbilisi, 0180, Georgia
TG Therapeutics Investigational Trial Site
RECRUITING

Tbilisi, 3700, Georgia
TG Therapeutics Investigational Trial Site
RECRUITING

Budapest, H-1033, Hungary
TG Therapeutics Investigational Trial Site
RECRUITING

Budapest, H-1145, Hungary
TG Therapeutics Investigational Trial Site
RECRUITING

Kaposvár, H-7400, Hungary
TG Therapeutics Investigational Trial Site
RECRUITING

Kistarsca, H-2143, Hungary
TG Therapeutics Investigational Trial Site
RECRUITING

Pécs, H-7623, Hungary
TG Therapeutics Investigational Trial Site
RECRUITING

Shtip, 7240, North Macedonia
TG Therapeutics Investigational Trial Site
RECRUITING

Skopje, 1000, North Macedonia
TG Therapeutics Investigational Trial Site
RECRUITING

Cherkasy, 14029, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Ivano-Frankivsk, 76000, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Ivano-Frankivsk, 76018, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Ivano-Frankivsk, 76493, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Kyiv, 03037, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Kyiv, 03115, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Lviv, 79000, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Lviv, 79010, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Ternopil, 46027, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Vinnytsia, 21002, Ukraine
TG Therapeutics Investigational Trial Site
RECRUITING

Vinnytsia, 21009, Ukraine

Conditions

Explore the condition pages connected to this study.

RELAPSING MULTIPLE SCLEROSIS